PRGO
Perrigo Co. Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$13.56
+0.59%Forward multiples
Based on analyst estimates
- P/E forward
- 5.74x
- P/E 2026E
- 5.99x
- P/E 2027E
- 5.46x
- P/E 2028E
- 4.93x
- P/S forward
- 0.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.75x
- Price / sales
- 0.45x
- Price / cash flow
- 7.47x
Enterprise value
- Enterprise value
- $4.8B
- EV / sales
- 1.15x
- EV / EBITDA
- -3.90x
- EV / EBIT
- 22.22x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026